Masterloc
Device Hip
General payments
$578,972
Research payments
$470,964
Through program year 2023, $578,972 in general payments and $470,964 in research payments were reported against Masterloc (Hip).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $6,739 | 35 |
| 2022 | General | $123,200 | 36 |
| 2021 | General | $140,507 | 37 |
| 2020 | General | $151,914 | 37 |
| 2020 | Research | $215,453 | 21 |
| 2019 | General | $156,611 | 47 |
| 2019 | Research | $255,511 | 29 |
Breakdown
The top 5 of 23 recipients; each share is of general payments naming this product in 2023.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 10 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
192 general · 50 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.